Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Non-Therapeutic Biomolecules Industry Expected To Reach By 2029, Starting From 2025 Levels?

The non-therapeutic biomolecules market has experienced substantial expansion in recent years. Its valuation is projected to increase from $30.76 billion in 2024 to $33.92 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.3%. The market’s past growth can be attributed to factors such as increased research and development (R&D) investments, expanding applications in research and diagnostics, rising awareness and adoption, strategic collaborations and partnerships, and regulatory support.

The non-therapeutic biomolecules market is projected to experience swift expansion over the coming years. This market is set to reach $51.03 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.8%. The anticipated growth during this period stems from factors such as new market opportunities, progress in data analytics and integration, a heightened emphasis on precision medicine, increased funding in personalized healthcare, and broader application domains. Key developments expected during the forecast period encompass technological innovations, strategic partnerships, a surge in agricultural applications, an enlarged presence in industrial processes, and enhanced customization along with personalization.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp

Which Drivers Are Impacting The Non-Therapeutic Biomolecules Market?

The non-therapeutic biomolecules market is projected to grow as the number of research and laboratory testing procedures rapidly increases. Laboratory testing refers to a medical process involving the analysis of blood, urine, or other bodily substances to identify and monitor diseases, thereby aiding in the creation of a treatment plan. Research, on the other hand, involves the generation of new knowledge or the innovative application of existing knowledge to establish new concepts, theories, and understandings. Non-therapeutic biomolecules are utilized in laboratory testing to assess the presence or concentration of a biomarker molecule indicative of disease, thereby enhancing the test’s sensitivity and specificity. For example, in July 2024, the National Health Service (NHS), a UK-based hospital and healthcare provider, stated that diagnostic activity in 2023 had surpassed pre-pandemic levels, with a 21% increase in tests performed in May 2024 compared to the previous year. Therefore, the rapidly growing volume of research and laboratory testing is a key driver for the expansion of the non-therapeutic biomolecules market.

What Are The Leading Segments Analyzed In The Non-Therapeutic Biomolecules Market?

The non-therapeutic biomolecules market covered in this report is segmented –

1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies

2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)

Subsegments:

1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes

2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors

3) By Plasmids: Research Plasmids, Expression Plasmids

4) By Peptides: Antimicrobial Peptides, Signaling Peptides

5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides

6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies

Which Competitive Trends Are Defining The Non-Therapeutic Biomolecules Market Structure?

Product innovation is a prominent trend gaining traction in the non-therapeutic biomolecules market. Leading companies operating in this sector are concentrating on research and development for product advancements to maintain their market position. For instance, in January 2022, BASF SE, a Germany-based multinational chemical company, partnered with Caregen, a Korean-based firm specializing in biomimetic peptide research and development. This collaboration led to the introduction of the Peptovitae series, manufactured using liposome-encapsulation technology, aiming to expand BASF’s dermo-cosmetics portfolio and offer innovative, differentiated solutions for a wide array of skin concerns. Liposomal encapsulation is a technique that utilizes fats to deliver essential vitamins or medications to specific body sections within tiny bubbles, without affecting other body parts. The Peptovitae series addresses a broader spectrum of skin issues than typically associated with peptides, such as signs of aging, enhancing skin brightness, soothing skin prone to dryness and itching, and moisturizing the skin.

Which Global Market Leaders Are Shaping The Future Of The Non-Therapeutic Biomolecules Sector?

Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Synlogic Inc., 3M Company, Eppendorf AG, Medtronic Plc, Bio-Techne Corporation, Iovance Biotherapeutics Inc., Vectalys, Avid Bioservices Inc., Sientra Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

How Do Regional Market Performances Compare Within The Non-Therapeutic Biomolecules Industry?

Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2024. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Non-Therapeutic Biomolecules Market Report:

https://www.thebusinessresearchcompany.com/customise?id=8769&type=smp

Browse Through More Reports Similar to the Global Non-Therapeutic Biomolecules Market 2025, By The Business Research Company

Small Animal Imaging In Vivo Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report

Renal Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report

Biologics Market 2025

https://www.thebusinessresearchcompany.com/report/biologics-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.